Since the last time I covered the pharmaceuticals giant AstraZeneca (NASDAQ:AZN) (OTCPK:AZNCF) in May this year, its share price is almost back to where...
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...
On July 27, before the market opened, Bristol-Myers Squibb (NYSE:BMY) released its Q2 2023 financial results, which, while failing to beat analysts’ expectations, were...
For all the attention that’s been paid to how toy-industry executive Ty Warner turned Beanie Babies into a can’t-keep-them-in-stock sensation some three decades ago,...
Investors need to exercise caution when choosing dividend-focused ETFs, as some categories may not be yielding the best returns in today’s market trends. For...